TransCode Therapeutics, Inc. Common Stock (RNAZ)

$5.34 +6.91%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-19 ESTIMATED
search

TransCode Therapeutics, Inc. Common Stock (RNAZ) has a 7-report earnings history dating back to Aug 23, 2021. Its average absolute post-earnings move is ±12.34%, and 57.1% of those reactions were positive. Its largest post-earnings gain was +6.21% (Nov 14, 2022) and its largest decline was -48.25% (Jan 16, 2024). The next earnings report is predicted for 2026-08-19 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

7

Avg Abs. Movement

±12.34%

Positive %

57.1%

Negative %

42.9%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Apr 05, 2024 ☽ POST $0.65 $0.65 $0.65 200 +1.23% open_in_new
Jan 16, 2024 ☽ POST $4.14 $4.14 $4.14 1,092 -48.25% open_in_new
Nov 14, 2023 ☽ POST $0.33 $0.33 $0.32 3,155 -10.29% open_in_new
Mar 31, 2023 ☽ POST $0.41 $0.41 $0.41 0 -16.17% open_in_new
Nov 14, 2022 ☽ POST $0.51 $0.53 $0.52 800 +6.21% open_in_new
Aug 15, 2022 ☽ POST $1.30 $1.30 $1.30 214 +0% open_in_new
Aug 23, 2021 ☽ POST $2.87 $2.87 $2.84 2,150 +4.23% open_in_new
event

Earnings Count

7

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.34%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
8-K 20260603 open_in_new SEC.gov
ARS 20260602 open_in_new SEC.gov
DEF 14A 20260602 open_in_new SEC.gov
8-K 20260601 open_in_new SEC.gov
8-K/A 20260526 open_in_new SEC.gov
DEFA14A 20260526 open_in_new SEC.gov
8-K 20260522 open_in_new SEC.gov
EFFECT 20260519 open_in_new SEC.gov
EFFECT 20260519 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov

Frequently asked about RNAZ earnings

When does TransCode Therapeutics, Inc. Common Stock report earnings next? expand_more

TransCode Therapeutics, Inc. Common Stock (RNAZ)'s next earnings date is estimated for 2026-08-19. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RNAZ stock move after earnings? expand_more

Over 7 reports, RNAZ has moved an average of ±12.34% the session after earnings, closing higher 57.1% of the time.

What was RNAZ's biggest post-earnings move? expand_more

RNAZ's largest post-earnings gain on record was +6.21% on Nov 14, 2022, and its largest decline was -48.25% on Jan 16, 2024.

Where can I find TransCode Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of TransCode Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers